Literature DB >> 24895180

Review: Occult hepatitis C virus infection: still remains a controversy.

Pavlina Dzekova Vidimliski1, Igor Nikolov, Nadica Matevska Geshkovska, Aleksandar Dimovski, Lionel Rostaing, Aleksandar Sikole.   

Abstract

Occult hepatitis C virus (HCV) infection is characterized by the presence of HCV RNA in the liver cells or peripheral blood mononuclear cells of the patients whose serum samples test negative for HCV RNA, with or without presence of HCV antibodies. The present study reviews the existing literature on the persistence of occult hepatitis C virus infection, with description of the clinical characteristics and methods for identification of occult hepatitis C. Occult hepatitis C virus infection was detected in patients with abnormal results of liver function tests of unknown origin, with HCV antibodies and HCV RNA negativity in serum, and also in patients with spontaneous or treatment-induced recovery from hepatitis C. The viral replication in the liver cells and/or peripheral blood mononuclear cells was present in all clinical presentations of occult hepatitis C. The peripheral blood mononuclear cells represent an extra-hepatic site of HCV replication. The reason why HCV RNA was not detectable in the serum of patients with occult hepatitis C, could be the low number of circulating viral particles not detectable by the diagnostic tests with low sensitivity. It is uncertain whether occult hepatitis C is a different clinical entity or just a form of chronic hepatitis C virus infection. Data accumulated over the last decade demonstrated that an effective approach to the diagnosis of HCV infection would be the implementation of more sensitive HCV RNA diagnostic assays, and also, examination of the presence of viral particles in the cells of the immune system.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HCV RNA; HCV antibodies; liver cells; occult hepatitis C; peripheral blood mononuclear cells

Mesh:

Substances:

Year:  2014        PMID: 24895180     DOI: 10.1002/jmv.23979

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis.

Authors:  Donatien Serge Mbaga; Sebastien Kenmoe; Jacky Njiki Bikoï; Guy Roussel Takuissu; Marie Amougou-Atsama; Etienne Atenguena Okobalemba; Jean Thierry Ebogo-Belobo; Arnol Bowo-Ngandji; Martin Gael Oyono; Jeannette Nina Magoudjou-Pekam; Ginette Irma Kame-Ngasse; Alex Durand Nka; Alfloditte Flore Feudjio; Cromwel Zemnou-Tepap; Elie Adamou Velhima; Juliette Laure Ndzie Ondigui; Rachel Audrey Nayang-Mundo; Sabine Aimee Touangnou-Chamda; Yrene Kamtchueng Takeu; Jean Bosco Taya-Fokou; Chris Andre Mbongue Mikangue; Raoul Kenfack-Momo; Cyprien Kengne-Ndé; Carole Stephanie Sake; Seraphine Nkie Esemu; Richard Njouom; Lucy Ndip; Sara Honorine Riwom Essama
Journal:  World J Methodol       Date:  2022-05-20

Review 2.  Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.

Authors:  Pier-Angelo Tovo; Carmelina Calitri; Carlo Scolfaro; Clara Gabiano; Silvia Garazzino
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

3.  Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response.

Authors:  Mahmoud A Khattab; Yehia Zakaria; Eslam Sadek; Aliaa S Abd El Fatah; Magdy Fouad; Muhammed Khattab; Hend M Moness; Nashwa Mohamed Adel; Elham Ahmed
Journal:  Clin Exp Med       Date:  2022-01-23       Impact factor: 3.984

4.  Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report.

Authors:  Borja Mora-Peris; Robert D Goldin; David Muir; Janice Main; Ricky Gellissen; Anthony Brown; Eleanor Barnes; Graham Cooke
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

5.  Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.

Authors:  Rujipat Wasitthankasem; Nawarat Posuwan; Preeyaporn Vichaiwattana; Apiradee Theamboonlers; Sirapa Klinfueng; Viboonsak Vuthitanachot; Napha Thanetkongtong; Siriporn Saelao; Monthana Foonoi; Apinya Fakthongyoo; Jamorn Makaroon; Klaita Srisingh; Duangporn Asawarachun; Somchai Owatanapanich; Norra Wutthiratkowit; Kraisorn Tohtubtiang; Pornsak Yoocharoen; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

6.  Occult HCV Infection (OCI) Diagnosis in Cirrhotic and Non-cirrhotic Naïve Patients by Intra-PBMC Nested Viral RNA PCR.

Authors:  Mohamed Darwish Ahmed Abd Alla; Saleh Ahmed Elibiary; George Y Wu; Mostafa Kamel El-Awady
Journal:  J Clin Transl Hepatol       Date:  2017-09-07

7.  Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort.

Authors:  Adriana Campa; Sabrina Sales Martinez; Kenneth E Sherman; Joe Pedro Greer; Yinghui Li; Stephanie Garcia; Tiffanie Stewart; Boubakari Ibrahimou; O Dale Williams; Marianna K Baum
Journal:  J Drug Abuse       Date:  2016-11-07

8.  Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality.

Authors:  Yijin Wang; Huiying Rao; Xiumei Chi; Boan Li; Hongyang Liu; Liyuan Wu; Hao Zhang; Shuhong Liu; Gaungde Zhou; Na Li; Junqi Niu; Lai Wei; Jingmin Zhao
Journal:  EBioMedicine       Date:  2019-07-23       Impact factor: 8.143

Review 9.  A New Twist to a Chronic HCV Infection: Occult Hepatitis C.

Authors:  Bashar M Attar; David Van Thiel
Journal:  Gastroenterol Res Pract       Date:  2015-06-24       Impact factor: 2.260

10.  High prevalence of occult hepatitis C infection in predialysis patients.

Authors:  Luís Henrique Bezerra Cavalcanti Sette; Edmundo Pessoa de Almeida Lopes; Nathália Campello Guedes Dos Anjos; Lucila Maria Valente; Sávio Augusto Vieira de Oliveira; Norma Lucena-Silva
Journal:  World J Hepatol       Date:  2019-01-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.